Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Elizabeth Williams, BA, Elizabeth Brown, Deepa Manwani, MD, Payal Desai, MD, Joshua J. Field, MD, Lynne D. Neumayr, Susan Padrino, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Ze Cong, PhD, Irene Agodoa, MD, Carolyn Hoppe, MD, Sophie M. Lanzkron, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2284.

https://doi.org/10.1182/blood-2019-124933

Published: 2019

Journal Articles

Patient Satisfaction of Care in the Treatment of Vaso-Occlusive Crises: A Comparison of Emergency Department and Infusion Centers in the Escaped Study

Blood (2018) 132 (Supplement 1): 314.

https://doi.org/10.1182/blood-2018-99-111544

Published: 2018

Journal Articles

Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the Grndad Registry

Matthew Sears, PhD, Sophie Lanzkron, MD MHS, Carolyn Hoppe, Joshua J. Field, MD, Payal C Desai, MD, Elizabeth Williams, Jane Little, MD

Blood (2018) 132 (Supplement 1): 158.

https://doi.org/10.1182/blood-2018-158

Published: 2018

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

Donna k McClish, PhD, Wally R. Smith, MD, Joshua J. Field, MD, Samir K. Ballas, MD, Claudia M Campbell, PhD, Lori E. Crosby, PhD, Carlton Dampier, MD, Deepika S. Darbari, MD, William Zempsky, MD

Blood (2018) 132 (Supplement 1): 3510.

https://doi.org/10.1182/blood-2018-99-114830

Published: 2018

Journal Articles

A Five Fold Decrease in Admissions for Uncomplicated Vaso-Occlusive Crisis and Other Benefits from Care in Infusion Clinics: Results from the Escaped Trial

Blood (2018) 132 (Supplement 1): 853.

https://doi.org/10.1182/blood-2018-99-111484

Published: 2018

Journal Articles

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Matthew Sears, Caroline Ewing, Sophie Lanzkron, MD, Joshua J. Field, MD, Carolyn C Hoppe, MD, Jane A. Little, MD

Blood (2017) 130 (Supplement 1): 3375.

https://doi.org/10.1182/blood.V130.Suppl_1.3375.3375

Published: 2017

Journal Articles

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Blood (2017) 130 (Supplement 1): 129.

https://doi.org/10.1182/blood.V130.Suppl_1.129.129

Published: 2017

Journal Articles

Daily Pain Is Associated with Alterations in Functional Connectivity of the Brain on fMRI in Adults with Sickle Cell Disease

Arun Singavi, MD, Guangyu Chen, Nancy Wandersee, PhD, Collin Hubler, Amanda M Brandow, DO, MS, Pippa Simpson, PhD, Shi-Jiang Li, PhD, Joshua J Field, MD

Blood (2016) 128 (22): 3656.

https://doi.org/10.1182/blood.V128.22.3656.3656

Published: 2016

Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD

Blood (2015) 126 (23): 2178.

https://doi.org/10.1182/blood.V126.23.2178.2178

Published: 2015

Journal Articles

Adult Patients with Stable Sickle Cell Disease Prior to Treatment with the iNKT Cell Depleting Antibody NKTT120 Have Consistent and Elevated Numbers of Activated (CD69 + ) iNKT Cells Relative to Healthy Adult Volunteers

Rosemary Mazanet, MD PhD, Robert Schaub, PhD, Felix Scheuplein, PhD, Cheryl A. Eaton, BA, Robert Mashal, MD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 4097.

https://doi.org/10.1182/blood.V124.21.4097.4097

Published: 2014

Journal Articles

Children with Sickle Cell Disease on Chronic Red Cell Transfusion Experience Fewer Hospitalizations for Acute Vaso-Occlusive Episodes Irrespective of the Indication for Transfusion

Carmen C Wallace, MD, Hilda Mata, Nancy J Wandersee, PhD, J. Paul Scott, MD, Amanda M Brandow, DO, MS, Joshua J. Field, MD MS, Matthew Karafin, MD, Cheryl A. Hillery, MD

Blood (2014) 124 (21): 4282.

https://doi.org/10.1182/blood.V124.21.4282.4282

Published: 2014

Journal Articles

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

Jonathan R. Lindner, MD, Michael Widlansky, MD, Melinda D. Wu, MD, Jillian Dargatz, RN, Leanne M. Harmann, RDCS, RDMS, RVT, Todd Belcik, BS, RCS, RDCS, Donna S. Neuberg, ScD, David G. Nathan, MD, Joel Linden, PhD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2705.

https://doi.org/10.1182/blood.V124.21.2705.2705

Published: 2014

Journal Articles

Higher Levels of Circulating Fibrocytes Are Associated with Lower Oxygen Saturation in Adults with Sickle Cell Disease

Joshua J. Field, MD MS, Borna Mehrad, MD, Marie Burdick, PhD, Kaushik Shahir, MD, Debora Nischik, RN, Pippa Simpson, PhD, Robert Strieter, MD, C. Edward Rose, MD

Blood (2014) 124 (21): 2710.

https://doi.org/10.1182/blood.V124.21.2710.2710

Published: 2014

Journal Articles

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Elaine M. Majerus, MD PhD, Kenneth I. Ataga, MD, Elliott Vichinsky, MD, Cheryl A. Eaton, BA, Rosemary Mazanet, MD PhD, David G. Nathan, MD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2718.

https://doi.org/10.1182/blood.V124.21.2718.2718

Published: 2014

Journal Articles

The Role Of NF-κB In The Activation Of Human iNKT Cells In Sickle Cell Disease Patients and In Vitro

Jennifer C. Yu, MD, Gene Lin, MD, PhD, Ruey Ken, PhD, Joshua J. Field, MD, MS, Joel Linden, PhD

Blood (2013) 122 (21): 2291.

https://doi.org/10.1182/blood.V122.21.2291.2291

Published: 2013

Journal Articles

Human Sickle Cell Disease Increases Numbers and Activation Of Peripheral Blood Myeloid Dendritic Cells, Monocytes, and Neutrophils

Gene Lin, MD, PhD, Jennifer C. Yu, MD, Joshua J. Field, MD, MS, David G. Nathan, MD, Joel Linden, PhD

Blood (2013) 122 (21): 1033.

https://doi.org/10.1182/blood.V122.21.1033.1033

Published: 2013

Journal Articles

An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost

Kathryn L. Koch, MSN, FNP-BC, Cynthia L. Leonard, MSN, RN, Katherine Bagemihl, MS, David Marks, MD, MBA, Thomas C. Abshire, Joshua J. Field, MD, MS

Blood (2013) 122 (21): 773.

https://doi.org/10.1182/blood.V122.21.773.773

Published: 2013

Journal Articles

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Joel Linden, PhD, Gene Lin, MD, PhD, Jennifer C. Yu, MD, Donna S. Neuberg, ScD, David G. Nathan, MD, Joshua J. Field, MD, MS

Blood (2013) 122 (21): 975.

https://doi.org/10.1182/blood.V122.21.975.975

Published: 2013

NARROW

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Patient Satisfaction of Care in the Treatment of Vaso-Occlusive Crises: A Comparison of Emergency Department and Infusion Centers in the Escaped Study

Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the Grndad Registry

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

A Five Fold Decrease in Admissions for Uncomplicated Vaso-Occlusive Crisis and Other Benefits from Care in Infusion Clinics: Results from the Escaped Trial

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Daily Pain Is Associated with Alterations in Functional Connectivity of the Brain on fMRI in Adults with Sickle Cell Disease

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Adult Patients with Stable Sickle Cell Disease Prior to Treatment with the iNKT Cell Depleting Antibody NKTT120 Have Consistent and Elevated Numbers of Activated (CD69 + ) iNKT Cells Relative to Healthy Adult Volunteers

Children with Sickle Cell Disease on Chronic Red Cell Transfusion Experience Fewer Hospitalizations for Acute Vaso-Occlusive Episodes Irrespective of the Indication for Transfusion

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

Higher Levels of Circulating Fibrocytes Are Associated with Lower Oxygen Saturation in Adults with Sickle Cell Disease

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

The Role Of NF-κB In The Activation Of Human iNKT Cells In Sickle Cell Disease Patients and In Vitro

Human Sickle Cell Disease Increases Numbers and Activation Of Peripheral Blood Myeloid Dendritic Cells, Monocytes, and Neutrophils

An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only